CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
PPP1R2 |
PPP1R2, IPP2: Protein phosphatase inhibitor 2 |
1.172 |
Evidence |
|
HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
1.172 |
Evidence |
|
HIST1H2BK |
HIST1H2BK, H2BFT, HIRIP1: Histone H2B type 1-K |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
H2BFS |
H2BFS: Histone H2B type F-S |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
DUSP14 |
DUSP14, MKP6: Dual specificity protein phosphatase 14 |
CLK3 |
CLK3: Dual specificity protein kinase CLK3 |
1.172 |
Evidence |
|
HIST1H2BJ |
HIST1H2BJ, H2BFR: Histone H2B type 1-J |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
1.172 |
Evidence |
|
CYP2C18 |
CYP2C18: Cytochrome P450 2C18 |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
1.17 |
Evidence |
|
CYP2B6 |
CYP2B6: Cytochrome P450 2B6 |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
1.17 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
YWHAE |
YWHAE: 14-3-3 protein epsilon |
1.17 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
1.17 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
1.17 |
Evidence |
|
ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
CRKL |
CRKL: Crk-like protein |
1.17 |
Evidence |
|
WASPIP |
IPI00552369 |
DCC |
DCC: Netrin receptor DCC precursor |
1.17 |
Evidence |
|
SOS1 |
SOS1: Son of sevenless homolog 1 |
TJP2 |
IPI00216245 |
1.17 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
1.17 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
1.17 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
1.17 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
TAGLN |
TAGLN, SM22, WS3-10: Transgelin |
1.17 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
1.17 |
Evidence |
|
CSPG4 |
CSPG4, MCSP: Chondroitin sulfate proteoglycan 4 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.17 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.17 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
RPS3 |
RPS3, OK/SW-cl.26: 40S ribosomal protein S3 |
1.17 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
1.17 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
NKX2-5 |
NKX2-5, CSX, NKX2.5, NKX2E: Homeobox protein Nkx-2.5 |
1.17 |
Evidence |
|